-
Study aim
-
The aim of this study was to compare the effect of traditional Anjebar booali daroo medicine and Mefenamic acid on abnormal uterine bleeding in women with high vaginal bleeding and age range of 20 to 45 years.
-
Design
-
Clinical trial with drug and control group with parallel and randomized triple blind groups
-
Settings and conduct
-
In this study, patients who referred to Izadi hospital due to vaginal bleeding were included.
Patients enter the study after entering the study, clinical examination and interview with a specialist physician.
In this study, patients will randomly receive a Anjebar booali daroo syrup with placebo capsule, and the other group will receive a mefenamic acid capsule each month with a placebo syrup.
Treatment duration is 3 menstrual cycles and severity of bleeding, quality of life and pain will be measured at the end of each cycle.A randomized, controlled, triple-blind clinical trial.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Patient satisfaction, bleeding more than 7 days or periods less than 21 days, Married women, Ages 20 -45 years, The Pap smear is normal, Blood tests is normal, Endometrial thickness in ultrasound is normal. Exclusion criteria:Hormone Therapy
Pregnancy and lactation,
diabetes, kidney disease, coagulants and cancers
Hypothyroidism and hyperthyroidism,
Sub-mucosal or intramural fibroids larger than 5 cm,
Active gastrointestinal bleeding,
Hemophilia
-
Intervention groups
-
Anjebar booali daroo syrup and placebo syrup. ake 15 ml every eight hour and Placebo capsule 250mg( pharmaceutical company Booali Daroo)Take one capsule every eight hour.Control:Placebo syrup(pharmaceutical company Booali Daroo).Take 15 ml every eight hour and Mefenamic acid capsule 250mg( pharmaceutical company Amin) Take one capsule every eight hour In three consecutive menstrual cycles.
-
Main outcome variables
-
severity of bleeding , quality of life and pain